148th Meeting of the National Advisory Council on Drug Abuse
Hybrid Meeting – September 11, 2024
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
| Time | Presentation |
|---|---|
| 10:30 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
| 10:45 a.m. | Council Review of Grant Applications Office of Research Training, Diversity, and Disparities Division of Epidemiology, Services, and Prevention Research (DESPR) Office of Translational Initiatives and Program Innovationa (OTIPI) Division of Therapeutics and Medical Consequences (DTMC) Division of Neuroscience and Behavior (DNB) Center for the Clinical Trials Network |
| 11:45 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Jeanette Marketon, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Join the Videocast.
Open Session
| Time | Presentation |
|---|---|
| 1:00 p.m. | Welcome and Opening Remarks Nora Volkow, M.D., Director, NIDA |
| 1:15 p.m. | Director's Report Nora Volkow, M.D., Director, NIDA |
| 2:00 p.m. | Discussion Council Members |
| 2:30 p.m. | The NIH BRAIN Initiative: Accelerating Discovery Toward Cures John Ngai, Ph.D. Director, BRAIN Initiative |
| 3:00 p.m. | Break |
| 3:15 p.m. | Addressing SDoH in the DNB and DESPR Portfolios Alexa Romberg, Ph.D. |
| 3:45 p.m. | People with Lived or Living Experience (PWLLE) NACDA Workgroup Rachel Tillage, Ph.D Health Science Policy Analyst, Science Policy Branch, OSPC |
| 4:00 p.m. | Concept Clearances |
| 4:45 p.m. | Public Comments |
| 5:00 p.m. | Adjourn |